> 本文内容由[Draft:子宮頸內膜異位症/2](https://zh.wikipedia.org/wiki/Draft:子宮頸內膜異位症/2)转换而来。




## 遺傳性原因

Endometriosis is a heritable condition that is influenced by both genetic and environmental factors.\[1\] Daughters or sisters of women with endometriosis are at higher risk of developing endometriosis themselves; low progesterone levels may be genetic, and may contribute to a hormone imbalance.\[2\] There is an approximate six-fold increased incidence in women with an affected first-degree relative.\[3\]

子宮內膜異位症是一種受遺傳和環境因素影響遺傳性疾病\[4\]。 二級血親中有直系女性親屬患有子宮內膜異位症的女性罹患子宮內膜異位症的風險較高；孕激素水平低可能是遺傳性原因，從而導致激素失衡。\[5\] 如果一級直系女性血親中有人患有此疾病，其發病率大約會增加六倍\[6\]。

It has been proposed that endometriosis results from a series of multiple hits within target genes, in a mechanism similar to the development of cancer.\[7\] In this case, the initial mutation may be either somatic or heritable.\[8\]

有研究指出，子宮內膜異位症是由靶基因內的多重打擊，其機制與癌症的發展過程類似。\[9\] 在這種情況下，初始的突變可能是體細胞的或者遺傳性的。\[10\]

Individual genomic changes (found by [genotyping](https://zh.wikipedia.org/wiki/genotyping "wikilink") including [genome-wide association studies](https://zh.wikipedia.org/wiki/Genome-wide_association_study "wikilink")) that have been associated with endometriosis include:\[11\]\[12\]\[13\]

與子宮內膜異位症相關的個體基因組變化（通過全基因組關聯分析發現）包括：\[14\]\[15\]\[16\]

<table>
<thead>
<tr class="header">
<th><p>染色體</p></th>
<th><p>基因/突變區</p></th>
<th><p>基因產物</p></th>
<th><p>功能</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><p>1</p></td>
<td><p><a href="https://zh.wikipedia.org/wiki/WNT4" title="wikilink">WNT4</a></p></td>
<td><p>Wingless-type MMTV integration site family member 4</p></td>
<td><p>Vital for development of the female reproductive organs 對女性生殖器官的發育至關重要</p></td>
</tr>
<tr class="even">
<td><p>2</p></td>
<td><p><a href="https://zh.wikipedia.org/wiki/GREB1" title="wikilink">GREB1</a>/FN1</p></td>
<td><p>Growth regulation by estrogen in breast cancer 1/Fibronectin 1 乳腺癌生長調節雌性激素1/Fibronectin 1</p></td>
<td><p>Early response gene in the estrogen regulation pathway/Cell adhesion and migration processes 雌激素調節過程/細胞黏附和遷移過程中的早期反應基因</p></td>
</tr>
<tr class="odd">
<td><p>6</p></td>
<td><p>ID4</p></td>
<td><p>Inhibitor of DNA binding 4 DNA結合蛋白抵制劑4</p></td>
<td><p>Ovarian oncogene, biological function unknown 卵巢癌基因，生物學功能未知</p></td>
</tr>
<tr class="even">
<td><p>7</p></td>
<td><p>7p15.2</p></td>
<td><p>Transcription factors 轉錄因子</p></td>
<td><p>Influence transcriptional regulation of uterine development 影響子宮發育的轉錄調節</p></td>
</tr>
<tr class="odd">
<td><p>9</p></td>
<td><p><a href="../Page/CDKN2BAS.md" title="wikilink">CDKN2BAS</a></p></td>
<td><p>Cyclin-dependent kinase inhibitor 2B antisense RNA</p></td>
<td><p>Regulation of tumour suppressor genes 抑制腫瘤基因的調節</p></td>
</tr>
<tr class="even">
<td><p>10</p></td>
<td><p>10q26</p></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p>12</p></td>
<td><p><a href="https://zh.wikipedia.org/wiki/VEZT" title="wikilink">VEZT</a></p></td>
<td><p>Vezatin, an adherens junction transmembrane protein Vezatin，一種粘連跨膜蛋白</p></td>
<td><p>抑制腫瘤基因</p></td>
</tr>
<tr class="even">
<td><p>19</p></td>
<td><p><a href="https://zh.wikipedia.org/wiki/MUC16" title="wikilink">MUC16</a> (CA-125)</p></td>
<td><p>Mucin 16, cell surface associated</p>
<p>黏蛋白 16，與細胞表面有關</p></td>
<td><p>Form protective mucous barriers 形成保護性粘膜</p></td>
</tr>
</tbody>
</table>

There are many findings of altered [gene expression](https://zh.wikipedia.org/wiki/gene_expression "wikilink") and [epigenetics](https://zh.wikipedia.org/wiki/epigenetics "wikilink"), but both of these can also be a secondary result of, for example, environmental factors and altered metabolism. Examples of altered gene expression include that of [miRNAs](https://zh.wikipedia.org/wiki/miRNA "wikilink").\[17\]

目前的研究中發現很多有關基因表达和表觀遺傳學的差異，但這兩者也可能是其他因素所導致的，例如環境因素或新陳代謝改變等。例如[miRNA等](https://zh.wikipedia.org/wiki/miRNA "wikilink")，可能會產生基因表達的差異。\[18\]

### Environmental toxins 環境因素

可能導致子宮內膜異位的一些因素包括：

  - prolonged exposure to estrogen; for example, in late menopause\[19\] or early menarche\[20\]\[21\]
  - 長期接觸雌激素；例如，更年期晚期\[22\] 或者月經初潮。\[23\]\[24\]
  - obstruction of menstrual outflow; for example, in Müllerian anomalies\[25\]
  - 月經不暢；例如，苗勒管发育异常。\[26\]

Several studies have investigated the potential link between exposure to [dioxins](https://zh.wikipedia.org/wiki/dioxin "wikilink") and endometriosis, but the evidence is equivocal and potential mechanisms are poorly understood.\[27\] A 2004 review of studies of dioxin and endometriosis concluded that "the human data supporting the dioxin-endometriosis association are scanty and conflicting",\[28\] and a 2009 follow-up review also found that there was "insufficient evidence" in support of a link between dioxin exposure and women developing endometriosis.\[29\] A 2008 review concluded that more work was needed, stating that "although preliminary work suggests a potential involvement of exposure to dioxins in the pathogenesis of endometriosis, much work remains to clearly define cause and effect and to understand the potential mechanism of toxicity".\[30\]

一些研究調查了二噁英暴露與子宮內膜異位之間的潛在聯繫，但其所提供的證據模棱兩可，對其潛在的機制也解釋不足。\[31\] 2004年發表的一份評論對二噁英與子宮內膜異位症關聯的研究現狀進行了總結：“能夠支持二噁英與子宮內膜異位症關聯的數據稀少且相互矛盾，”\[32\] 2009年發表的一份跟進評論也發現“缺乏足夠的證據”來證明二噁英與子宮內膜異位症之間的聯繫\[33\] 一份2008年的評論文章提出目前仍然需要更多此方面的工作：“儘管一些初步的研究顯示了暴露於二噁英的環境可能誘發子宮內膜異位症，但仍需進行大量的研究來明確其具體因果關係、並了解其潛在的毒性機制。”\[34\]

1.
2.  Kapoor D, Davila W (2005). [Endometriosis,](http://www.emedicine.com/med/topic3419.htm)  *eMedicine*.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.